Question 1

Has Leila Haghighat, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $5,928 in general payments to Leila Haghighat, MD across 49 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Leila Haghighat, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Leila Haghighat, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Edwards Lifesciences	23	$2,706
Abbott	13	$1,940
Heartflow, Inc.	3	$366
Boston Scientific	2	$256
Paragonix Technologies, Inc.	3	$160
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$150
Amgen	1	$140
E.r. Squibb & Sons, L.L.C.	1	$118
Terumo Medical Corporation	1	$93

Leila Haghighat, MD

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Medicare billing

Other cardiovascular disease in Burlingame